Thomas Bock

Title: Thomas Bock: Innovator in Pharmaceutical Formulations

Introduction

Thomas Bock is a notable inventor based in Walchwil, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative dosage forms. His work focuses on enhancing the efficacy and delivery of pharmaceutical compounds.

Latest Patents

Thomas Bock holds a patent for a capsule pharmaceutical dosage form comprising a suspension formulation of an indolinone derivative. This invention relates to a suspension formulation containing the active substance 3-Z-[1-(4-(N-((4-methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone-monoethanesulphonate. The patent details a capsule pharmaceutical dosage form that contains this suspension formulation, along with processes for preparing both the suspension and the capsule, as well as the packaging material for the finished product.

Career Highlights

Thomas Bock is associated with Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His work at the company has been instrumental in advancing pharmaceutical formulations and improving patient outcomes through innovative drug delivery systems.

Collaborations

Throughout his career, Thomas has collaborated with esteemed colleagues such as Roman Messerschmid and Rudolf Binder. These collaborations have contributed to the successful development of his patented formulations and have fostered a culture of innovation within his team.

Conclusion

Thomas Bock's contributions to pharmaceutical innovations exemplify the impact of dedicated inventors in the healthcare industry. His patent for a novel capsule dosage form showcases his commitment to improving drug delivery and patient care.